Rare diseases
Investigational molecules
Locations
50 Hampshire Street Ste 402, 02139-1893, United States
Kanyos Bio Inc. focuses on celiac disease, with clinical research centered on the intestinal consequences of gluten exposure and the protection of duodenal mucosa. Its work reflects interest in restoring normal small bowel structure and limiting disease-related tissue injury.
The sponsor’s clinical activity is directed toward measuring changes in intestinal architecture associated with gluten-triggered disease activity in celiac disease.
Kanyos Bio Inc. runs clinical trials in conditions such as Coeliac disease, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FinlandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
